reference/15311760

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15311760

Outgoing Links

Predicate	Object
contentType	Case Reports\|Letter
endingPage	433
issn	1029-2403 1042-8194
issueIdentifier	2
pageRange	431-433
publicationName	Leukemia & Lymphoma
startingPage	431
bibliographicCitation	Yamagata M, Murohisa T, Tsuchida K, Okamoto Y, Tsunoda S, Nakamura M, Kusano K, Majima Y, Kuniyoshi T, Iijima M, Sugaya H, Hiraishi H. Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab. Leuk Lymphoma. 2007 Feb;48(2):431–3. doi: 10.1080/10428190601059704. PMID: 17325912.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a71f6eea407e02cd72d1c3f5948fcb51 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d012ccac591f1dfa9edb1899324890e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d1caa6980e0921d84f008d0e5bb86af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc1c7047bee25afa9a88f70b9fc3b4dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46edf13db72745557c612a566d76fb12 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7155b3559bbe04ad0f8bfbeab80ae7a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66ce6b5995d2ecd5e7d736a9586c1603 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee86f374e05b069d8d3c796ea67fa799 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f53f9de8a8dae823da557e46b1288188 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_904e05a482dea644fd4d098af2e66d06 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2db166771a25e2dfd9cfea2f619fd1c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c87c21aab92259694caf3eef7ffa13a3
date	200701
identifier	https://pubmed.ncbi.nlm.nih.gov/17325912 https://doi.org/10.1080/10428190601059704
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2306 https://portal.issn.org/resource/ISSN/1029-2403 https://portal.issn.org/resource/ISSN/1042-8194
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab
discusses	http://id.nlm.nih.gov/mesh/M0006695 http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0544940 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0001357
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D004279Q000235 http://id.nlm.nih.gov/mesh/D006509Q000209 http://id.nlm.nih.gov/mesh/D006515Q000235 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D016403Q000188 http://id.nlm.nih.gov/mesh/D016393Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D014750Q000627 http://id.nlm.nih.gov/mesh/D004279Q000097 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016393Q000097 http://id.nlm.nih.gov/mesh/D011241Q000627 http://id.nlm.nih.gov/mesh/D016393Q000150 http://id.nlm.nih.gov/mesh/D006509Q000235 http://id.nlm.nih.gov/mesh/D006509Q000097 http://id.nlm.nih.gov/mesh/D016403Q000150 http://id.nlm.nih.gov/mesh/D058846 http://id.nlm.nih.gov/mesh/D006515Q000378 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004317Q000627 http://id.nlm.nih.gov/mesh/D000069283 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D003520Q000627 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D016403Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9981 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9859

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 69.